<DOC>
	<DOCNO>NCT00290329</DOCNO>
	<brief_summary>GlaxoSmithKline Philippines submit registration file Purified Meningococcal Polysaccharide Serogroup ACWY Vaccine ( Mencevax ACWY ) . This study conduct collect clinical data local target population order assess occurrence rare adverse event vaccination per requirement Philippines Bureau Food Drugs Directive .</brief_summary>
	<brief_title>Safety Purified Meningococcal Vaccine With Serogroups ACWY , 3,000 Filipino Subjects Aged &gt; 2 Years</brief_title>
	<detailed_description>All subject receive single dose GSK Biologicals ' Mencevax ACWY vaccine accord prescribe information . Subjects stratify follow age group : 2 5 year 6 17 year &gt; 18 year The Protocol Posting update order comply FDA Amendment Act , September 2007 .</detailed_description>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe and/or parent/guardian comply requirement protocol . A Filipino male female &gt; 2 year age time first vaccination . Free obvious health problem establish medical history clinical examination enter study . Written inform consent obtain subject and/or parent/ guardian subject . Exclusion criterion : Subjects suffer acute severe febrile illness . History allergic disease reaction likely exacerbate component vaccine . Major congenital defect serious chronic illness . History neurologic disorder seizure . Pregnant lactate female . Female plan become pregnant . History chronic alcohol consumption and/or intravenous drug abuse . Any contraindication state Prescribing Information .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Meningococcal disease</keyword>
	<keyword>Meningitidis serogroups A , C , W &amp; Y disease</keyword>
	<keyword>Meningococcal vaccine</keyword>
</DOC>